Table: Torii Pharmaceutical -2023 parent results
Feb 9 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 54.64 48.90 58.60
(+11.7 pct) (+7.3 pct)
Operating 5.04 5.54 5.80
(-9.1 pct) (+19.0 pct) (+15.2 pct)
Recurring 5.31 5.54 6.20
(-4.1 pct) (+14.2 pct) (+16.8 pct)
Net 4.12 3.94 4.70
(+4.4 pct) (+16.9 pct) (+14.1 pct)
EPS 146.60 yen 140.39 yen 167.23 yen
Ann Div 120.00 yen 100.00 yen 120.00 yen
-Q2 Div 50.00 yen 24.00 yen 60.00 yen
-Q4 Div 70.00 yen 76.00 yen 60.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)